Mark Eccleston

1PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 29, 2025
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines.

Maryam Latarani, Perla Pucci, Mark Eccleston

Pageof 1